Schweizerische Gesellschaft für Pharmazeutische Medizin, Jahrestagung, Zürich
Evidence shows: personalized medicine is an intervention with a very low baseline risk and with a positive impact on cost reduction. Moreover, perzonalised medicine means greater patient safety and better handling of financial resources. While it has become an integral part of today's medicine, we soon realize that key requirements of personalized medicine still haven’t been put in place.
Zur Präsentation (PDF, 2MB) (auf Englisch)